Literature DB >> 381322

Pancreatic alpha-cell function in diabetic hemochromatotic subjects.

R L Nelson, W P Baldus, A H Rubenstein, V L Go, F J Service.   

Abstract

To clarify further the etiology of the carbohydrate intolerance in idiopathic hemochromatosis, we investigated the glucose, insulin, C-peptide, and glucagon responses to arginine (0.5 g/kg) infused during 30 min in lean normal subjects; in insulin-requiring subjects with hemochromatosis, genetic diabetes, and total pancreatectomy; and in nondiabetic cirrhotic subjects without portosystemic shunting. Serum insulin, C-peptide, and glucagon responses (30K antibody) were determined by RIA, and glucose level was determined by a glucose oxidase technique. Hemochromatotic and genetic diabetic subjects had similar basal glucose (157 +/- 25 vs. 168 +/- 40 mg/dl) and C-peptide (0.73 +/- 0.42 vs. 0.65 +/- 0.22 ng/ml) values, with subnormal C-peptide peak responses to stimulation (1.05 +/- 0.38 and 1.40 +/- 0.83 vs. 3.95 +/- 0.4 ng/ml in normals; P less than 0.05). No glucagon or C-peptide response to arginine was seen in any pancreatectomized subject. Similar but excessive glucagon levels were present in hemochromatosis, diabetes, and cirrhosis under basal conditions (166 +/- 24, 232 +/- 111, and 263 +/- 116 vs. 76 +/- 15 pg/ml; P less than 0.05) and after arginine stimulation (782 +/- 80, 834 +/- 123, and 902 +/- 275 vs. 489 +/- 81 pg/ml; P less than 0.05) when compared with normals. The excessive glucagon levels found in hemochromatosis, diabetes mellitus, and cirrhosis contrast to the absent response in pancreatectomized subjects and indicate that generalized islet cell destruction is not the major factor in diabetic hemochromatotic subjects.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 381322     DOI: 10.1210/jcem-49-3-412

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Absence of islet alpha cell function in pancreatectomized patients.

Authors:  A Tiengo; M Bessioud; I Valverde; A Tabbi-Anneni; S Delprato; J Alexandre; R Assan
Journal:  Diabetologia       Date:  1982-01       Impact factor: 10.122

2.  The haemochromatotic human pancreas: a quantitative immunohistochemical and ultrastructural study.

Authors:  J Rahier; S Loozen; R M Goebbels; M Abrahem
Journal:  Diabetologia       Date:  1987-01       Impact factor: 10.122

3.  Exocrine pancreatic insufficiency and idiopathic haemochromatosis.

Authors:  P L Jansen; T Thien; C B Lamers; S H Yap; P Reekers; S Strijk
Journal:  Postgrad Med J       Date:  1984-10       Impact factor: 2.401

4.  Hereditary hemochromatosis.

Authors:  Stephen A Geller; Fernando P F de Campos
Journal:  Autops Case Rep       Date:  2015-03-30

Review 5.  Diabetes in HFE Hemochromatosis.

Authors:  James C Barton; Ronald T Acton
Journal:  J Diabetes Res       Date:  2017-02-26       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.